Furthermore, the present study demonstrated a significant positive correlation between plasma LCAT and PON-1, suggesting that the two lipoprotein-associated enzymes may play synergistic roles on HDL particles to counter the effects of atherosclerosis and ASCVD progression. The gene discussed is LCAT; the disease is atherosclerosis.